347 related articles for article (PubMed ID: 32830245)
1. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.
Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E; García-Serra A; Maudes E; Pedreño M; Paul S; Doherty J; Quirk M; Dai J; Gasull X; Lewis M; Dalmau J
Brain; 2020 Sep; 143(9):2709-2720. PubMed ID: 32830245
[TBL] [Abstract][Full Text] [Related]
2. Allosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in Mice.
Radosevic M; Planagumà J; Mannara F; Mellado A; Aguilar E; Sabater L; Landa J; García-Serra A; Maudes E; Gasull X; Lewis M; Dalmau J
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34903638
[TBL] [Abstract][Full Text] [Related]
3. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice.
Planagumà J; Leypoldt F; Mannara F; Gutiérrez-Cuesta J; Martín-García E; Aguilar E; Titulaer MJ; Petit-Pedrol M; Jain A; Balice-Gordon R; Lakadamyali M; Graus F; Maldonado R; Dalmau J
Brain; 2015 Jan; 138(Pt 1):94-109. PubMed ID: 25392198
[TBL] [Abstract][Full Text] [Related]
4. Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity.
Planagumà J; Haselmann H; Mannara F; Petit-Pedrol M; Grünewald B; Aguilar E; Röpke L; Martín-García E; Titulaer MJ; Jercog P; Graus F; Maldonado R; Geis C; Dalmau J
Ann Neurol; 2016 Sep; 80(3):388-400. PubMed ID: 27399303
[TBL] [Abstract][Full Text] [Related]
5. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
[No Abstract] [Full Text] [Related]
6. Positive Allosteric Modulation of NMDARs Prevents the Altered Surface Dynamics Caused by Patients' Antibodies.
Maudes E; Jamet Z; Marmolejo L; Dalmau JO; Groc L
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200261. PubMed ID: 38771989
[TBL] [Abstract][Full Text] [Related]
7. Memory loss and aberrant neurogenesis in mice exposed to patient anti-N-methyl-d-aspartate receptor antibodies.
Taraschenko O; Fox HS; Heliso P; Al-Saleem F; Dessain S; Kim WY; Samuelson MM; Dingledine R
Exp Neurol; 2024 Aug; 378():114838. PubMed ID: 38801989
[TBL] [Abstract][Full Text] [Related]
8. NMDAR Antibodies Alter Dopamine Receptors and Cause Psychotic Behavior in Mice.
Carceles-Cordon M; Mannara F; Aguilar E; Castellanos A; Planagumà J; Dalmau J
Ann Neurol; 2020 Sep; 88(3):603-613. PubMed ID: 32583480
[TBL] [Abstract][Full Text] [Related]
9. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis.
Moscato EH; Peng X; Jain A; Parsons TD; Dalmau J; Balice-Gordon RJ
Ann Neurol; 2014 Jul; 76(1):108-19. PubMed ID: 24916964
[TBL] [Abstract][Full Text] [Related]
10. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.
Hughes EG; Peng X; Gleichman AJ; Lai M; Zhou L; Tsou R; Parsons TD; Lynch DR; Dalmau J; Balice-Gordon RJ
J Neurosci; 2010 Apr; 30(17):5866-75. PubMed ID: 20427647
[TBL] [Abstract][Full Text] [Related]
11. N-Methyl-D-Aspartate Receptor Antibodies in Autoimmune Encephalopathy Alter Oligodendrocyte Function.
Matute C; Palma A; Serrano-Regal MP; Maudes E; Barman S; Sánchez-Gómez MV; Domercq M; Goebels N; Dalmau J
Ann Neurol; 2020 May; 87(5):670-676. PubMed ID: 32052483
[TBL] [Abstract][Full Text] [Related]
12. Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices.
Sun MY; Izumi Y; Benz A; Zorumski CF; Mennerick S
J Neurophysiol; 2016 Mar; 115(3):1263-72. PubMed ID: 26745248
[TBL] [Abstract][Full Text] [Related]
13. Blocking Placental Class G Immunoglobulin Transfer Prevents NMDA Receptor Antibody Effects in Newborn Mice.
García-Serra A; Radosevic M; Ríos J; Aguilar E; Maudes E; Landa J; Sabater L; Martinez-Hernandez E; Planagumà J; Dalmau J
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34580181
[TBL] [Abstract][Full Text] [Related]
14. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.
Paul SM; Doherty JJ; Robichaud AJ; Belfort GM; Chow BY; Hammond RS; Crawford DC; Linsenbardt AJ; Shu HJ; Izumi Y; Mennerick SJ; Zorumski CF
J Neurosci; 2013 Oct; 33(44):17290-300. PubMed ID: 24174662
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic injection of cerebrospinal fluid from anti-NMDA receptor encephalitis into rat dentate gyrus impairs NMDA receptor function.
Würdemann T; Kersten M; Tokay T; Guli X; Kober M; Rohde M; Porath K; Sellmann T; Bien CG; Köhling R; Kirschstein T
Brain Res; 2016 Feb; 1633():10-18. PubMed ID: 26721688
[TBL] [Abstract][Full Text] [Related]
16. Seizures and memory impairment induced by patient-derived anti-N-methyl-D-aspartate receptor antibodies in mice are attenuated by anakinra, an interleukin-1 receptor antagonist.
Taraschenko O; Fox HS; Zekeridou A; Pittock SJ; Eldridge E; Farukhuddin F; Al-Saleem F; Devi Kattala C; Dessain SK; Casale G; Willcockson G; Dingledine R
Epilepsia; 2021 Mar; 62(3):671-682. PubMed ID: 33596332
[TBL] [Abstract][Full Text] [Related]
17. Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel.
Emnett CM; Eisenman LN; Mohan J; Taylor AA; Doherty JJ; Paul SM; Zorumski CF; Mennerick S
Br J Pharmacol; 2015 Mar; 172(5):1333-47. PubMed ID: 25377730
[TBL] [Abstract][Full Text] [Related]
18. A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis.
Taraschenko O; Fox HS; Pittock SJ; Zekeridou A; Gafurova M; Eldridge E; Liu J; Dravid SM; Dingledine R
Epilepsia; 2019 Mar; 60(3):452-463. PubMed ID: 30740690
[TBL] [Abstract][Full Text] [Related]
19. Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients.
Zhang Q; Tanaka K; Sun P; Nakata M; Yamamoto R; Sakimura K; Matsui M; Kato N
Neurobiol Dis; 2012 Jan; 45(1):610-5. PubMed ID: 22008231
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.
Hara M; Martinez-Hernandez E; Ariño H; Armangué T; Spatola M; Petit-Pedrol M; Saiz A; Rosenfeld MR; Graus F; Dalmau J
Neurology; 2018 Apr; 90(16):e1386-e1394. PubMed ID: 29549218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
